Hyphens Pharma International Limited (SGX:1J5)

Revenue by Segment

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Digital Platform and E-Pharmacy	39.37M	43.63M	42.75M	43.22M	41.19M
Pharmaceutical and Medical Aesthetics	101.33M	124.25M	102.20M	95.66M	65.62M
Proprietary Brands	36.67M	27.55M	25.65M	23.44M	19.07M
Total	177.37M	195.42M	170.60M	162.32M	125.88M

Revenue by Geography

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Singapore	93.20M	90.89M	85.00M	84.55M	64.11M
Vietnam	39.53M	57.11M	49.01M	54.55M	41.61M
Malaysia	27.37M	25.78M	17.23M	15.12M	10.64M
Others	17.27M	21.63M	19.36M	8.10M	9.53M
Total	177.37M	195.42M	170.60M	162.32M	125.88M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 25, 2026

Data Sources Report a data error